Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial
Novo Nordisk A/S shares surged after a key study backed the use of Wegovy, its blockbuster weight-loss drug,
1970-01-01 08:00
Wegovy's heart benefits due to more than weight loss, Novo says
By Patrick Wingrove PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity
1970-01-01 08:00
Trump’s Bet in Iowa, Wegovy Study: Your Saturday US Briefing
Good morning from Washington, where Congress is up against a Nov. 17 deadline when government funding runs out.Donald
1970-01-01 08:00
Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease
Novo Nordisk A/S unveiled details from a closely watched study that support use of Wegovy, its blockbuster weight-loss
1970-01-01 08:00
Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits
The craze around pricey weight-loss drugs has many people clamoring for these treatments in company-sponsored health plans. While
1970-01-01 08:00
Novo to Build $6 Billion Plant as Obesity Drug Demand Surges
Novo Nordisk A/S will invest more than 42 billion kroner ($6 billion) to expand its manufacturing facilities as
1970-01-01 08:00
Drugmaker Novo Nordisk seeks obesity, diabetes 'bolt-on' deals
By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN Novo Nordisk wants to buy more companies with drugs in early-
1970-01-01 08:00
Weight-loss drug maker Novo Nordisk invests $6 billion to boost output
COPENHAGEN Novo Nordisk said on Friday it will invest more than 42 billion crowns ($6 billion) in its
1970-01-01 08:00
Astra Enters Obesity Drug Race With Chinese Biotech Deal
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines, agreeing
1970-01-01 08:00
New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper
An effective and massively popular weight-loss drug has made Novo Nordisk A/S billions of dollars and turned it
1970-01-01 08:00
Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic
Eli Lilly & Co. won US approval for its diabetes drug to treat obesity, unlocking blockbuster sales potential
1970-01-01 08:00
European Stocks On Track for Best Run Since July on Fed Optimism
European shares advanced for a fourth day, set for their longest winning streak since July, fueled by hopes
1970-01-01 08:00